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Abstract 
Background: Early Warning Score (EWS) is a physiological composite score of six bedside vital parameters, routinely 
used in UK hospitals. We evaluated the prognostic ability of EWS in Gram-negative bacteraemia causing sepsis.
Methods: We prospectively evaluated EWS as a marker of severity and prognosis in adult patients with Gram-nega-
tive bacteraemia. All adult patients with Gram-negative bacteraemia admitted to our tertiary Teaching hospital of the 
National Health Service in England were enrolled over 1 year period. The highest daily EWS score was recorded from 
7 days before to 14 days after the date of onset of bacteraemia. The primary outcome was 28-day mortality.
Main results: A total of 245 consecutive adult patients with Gram-negative bacteraemia with sepsis were enrolled. 
On multivariate analysis, following variables were associated with death for every single unit change (odds ratio in 
the brackets): higher age (1.05), lower mean arterial pressure (1.03), lower serum bicarbonate (1.08), higher EWS (1.27), 
higher SOFA score (1.36), hospital-onset of infection (5.43) and need for vasopressor agents (16.4). EWS on day 0, 1, 2, 
and average 14-day score were significantly higher in patients who died by 28 days from the onset of bacteraemia 
[95 % CI 0.4–0.6] p < 0.001. A stepwise rise in EWS and failure of improvement in EWS by 2 points 48 h after the onset 
of bacteraemia were associated with poor outcome.
Conclusion: EWS is a simple and cost-effective bedside tool for the assessment of severity and prognosis of sepsis 
caused by Gram-negative bacteraemia.
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Background
Sepsis is a leading cause of death across all age groups 
around the world, with an estimated incidence of 20–30 
million cases each year [1]. The hospitalisation rate for 
sepsis has doubled in recent years in the United States 
from 11.6 to 24 per 10,000 population, and has even sur-
passed that of acute myocardial infarction [2, 3]. In the 
United Kingdom, the conservative annual estimates from 
Intensive Care National Audit and Research (ICNARC) 
data suggests that  >100,000 cases with around 37,000 
deaths occur each year as a result of sepsis, more than 
HIV/AIDS, prostate and breast cancer added together 
[4]. Blood stream infections (BSI) are an important cause 
of sepsis [5]. In the year 2013, 97,699 patient episodes 
of BSI were reported in UK and 58.3  % were caused by 
Gram-negative bacteria [6]. The incidence of Gram-neg-
ative BSI (GNBSI) has increased in the last 5 years in the 
UK compounded by increasing antimicrobial resistance 
[6, 7].
Sepsis is a systemic inflammatory disorder driven 
by infection and is the most common final pathway of 
death in infectious diseases [8]. Over 100 inflamma-
tion, immune and metabolic markers are known to show 
abnormal levels in the presence of sepsis. However none 
of these markers either in single or in combination can 
reliably grade the severity of sepsis or predict clinical 
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outcome [9]. Therefore a reliable, cost-effective bedside 
test or parameter to grade the severity of sepsis to predict 
clinical outcome is urgently needed.
Early Warning Score (EWS) is a composite score of six 
bedside vital parameters: pulse rate, blood pressure (BP), 
oxygen saturation (SpO2), body temperature, respira-
tory rate, and mental state. EWS is recorded routinely 
in all inpatients admitted to national health service 
(NHS) hospitals in England as per National Institute of 
Health Care and Excellence (NICE) guidelines and it has 
become a standard of care in all NHS hospitals in Eng-
land since 2007 [10]. There are slight modifications to 
grade EWS at different healthcare organisations to suit 
the local patient population and also to make it more 
user friendly.
We evaluated the utility of EWS in grading the severity 
of illness and predicting clinical outcome of patients with 
sepsis caused by GNBSI.
Methods
Study design, setting, and patients
We conducted a prospective, observational, non-inter-
ventional single centre cohort study in a tertiary teaching 
NHS hospital in England. All consecutive adult patients 
(>18 years) with a positive blood culture growing Gram-
negative bacteria were enrolled (2011–2012). Patients 
were prospectively identified from the Department of 
Microbiology soon after the blood cultures flagging posi-
tive and the Gram stain showing the presence of Gram-
negative bacteria. We excluded following patients (1) 
Paediatric patients (≤18  years of age), (2) any patients 
where cultures were deemed as contaminants, (3) any 
patients where follow-up to 28 days or primary outcome 
was not possible e.g. self-discharge or transfer to another 
healthcare facility.
Data collection
All patients were evaluated, enrolled, monitored, and 
followed-up by the same clinical infection team including 
all data entry. All demographic, clinical, bacterial (iden-
tification and susceptibility data), antibiotic therapy and 
follow-up data were collected into a specifically designed 
data collection form (DCF). The results were manually 
entered onto the DCF on a daily basis during routine 
normal working hours. The data was subsequently trans-
ferred into a database created specifically for the study 
(Microsoft® Access 2010).
Ethics
A formal ethical approval of the study was obtained from 
the North Bristol NHS Trust clinical research and effec-
tiveness department, and formal patient consent was 
exempted for the purposes of this study.
Definitions
Bacteraemia was defined as polymicrobial if more than 
one pathogenic organism was isolated in the blood cul-
tures. The likely source of bacteraemia was determined 
based on clinical assessment from the infection special-
ists, radiological, endoscopic, and surgical (operative the-
atre) findings. Time to source control was defined as an 
interval between time of collection of blood cultures and 
performing an intervention such as draining an abscess 
or removing an infected central venous catheter. Time to 
first antibiotic is defined as an interval between collection 
of blood cultures and receiving the first dose of antibiotic 
for which the isolate is tested susceptible by British Soci-
ety of Antimicrobials and Chemotherapy (BSAC) in vitro 
method [11]. Time to appropriate therapy is defined as 
time to receiving the first dose of antibiotic(s) which is 
clinically appropriate based on susceptibility pattern, 
source of bacteraemia, breadth of spectrum to cover all 
significant isolates. Co-morbidity of patients was meas-
ured by means of age-corrected Charlson’s Co-morbid-
ity index (CCMI) and severity of organ dysfunction was 
measured by using Sequential Organ Failure Assessment 
(SOFA) score [12, 13]. The acute physiological derange-
ments caused by Gram-negative bacteraemia was meas-
ured by standard bedside cardio-respiratory parameters 
[such as blood pressure, oxygen saturation (SpO2) etc.] 
throughout inpatient stay (Additional file 1). Daily highest 
EWS score was recorded from 7 days prior (for hospital-
onset cases only) to 14 days after the onset of GNBSI. If 
EWS score was not recorded as a part of the routine care 
in selective areas (e.g. obstetrics), we derived it based on 
the acute physiological parameters as enlisted earlier.
Outcomes
Primary outcome was defined as all-cause 28-day mortal-
ity from the time of collection of blood cultures.
Statistical analysis
All scale (quantitative) variables are reported as 
mean  ±  standard deviation (SD). The categorical vari-
ables (nominal) are reported as percentages. We used 
student t test to compare the continuous (scale) variables 
and χ2 test to compare the categorical variables. Mann–
Whitney test was used for variables with a non-normal 
distribution. Differences between the groups were con-
sidered statistically significant at a p value of  <0.05 and 
all tests were 2-sided with a 95 % confidence interval (CI). 
Multivariate analyses was carried out by using logistic 
regression and employed backwards stepwise variable 
elimination (with variable exit threshold at p  >  0.05) to 
procure minimal adequate models. Survival analysis was 
performed by means of Kaplan–Meier curves. Receiver 
Operating Characteristic (ROC) analysis was performed 
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to assess the prognostic value of EWS. All statistical anal-
yses were performed by using SPSS 19.0 (SPSS, Chicago, 
IL, USA).
Results
Epidemiological, clinical and bacterial characteristics  
of the entire cohort
During the study period, 252 non-duplicate consecutive 
episodes of GNBSI were reported in our centre. Three 
of them were deemed contaminants, one patient lost to 
follow-up, and three were transferred to other health 
care centres. Therefore 245 patients were included in the 
final analysis of the cohort. About a third of them (35 %) 
were hospital-onset and two-thirds (65 %) were commu-
nity-onset. The majority of GNBSI were in medical units 
(60  %) followed by surgical units (24  %) and the Emer-
gency Department (11 %). E. coli was the most common 
pathogen (65.3  %) followed by Klebsiella spp. (12.7  %). 
Other bacteria identified included Enterobacteriaceae 
(12.7  %), non-fermenters (8.6  %) and Gram-negative 
anaerobes (3.7  %). 9  % of blood cultures were polymi-
crobial and 5  % were extended-spectrum β-lactamases 
(ESBL) producers. Diabetes mellitus (24  %) was the 
most common co-morbid medical condition followed by 
chronic kidney disease (23 %).
Primary outcome
Overall the 28-day mortality in our cohort was 22.4  %, 
and in-patient mortality was 26.5 %.
Source of GNBSI
The urinary tract was the most common source of bac-
teraemia (39  %) and the source was unknown in about 
18 %. The source of GNBSI and their impact on 28-day 
mortality are shown in Table 1. Only 21 out of 245 (8.2 %) 
patients underwent source control intervention in our 
cohort. The nature of intervention was dependent on the 
source e.g. CVC line removal, draining a collection etc. 
Mean time to source control was 38.8  ±  46.5  h with a 
median of 20.9 h (range 0–179 h). Mean time to source 
control for patients who died before 28 days (3.82 ± 20 h) 
was not significantly different than those who survived 
(28.5 ± 51.1 h) p = 0.18, 95 % [CI −3.1 to 0.64].
Comparative findings for primary outcome
Univariate analyses of continuous and categorical varia-
bles for patients who died or survived at 28-days from the 
onset of GNBSI are shown in Table 2. On univariate anal-
ysis, following factors had an impact on primary clinical 
outcome: old age, high comorbidity score, higher SOFA 
score, hypotension, hypothermia, high CRP, lower time 
to positivity of blood cultures, time to first antibiotic, 
hospital-onset of BSI, requirement of oxygen and vaso-
pressors, polymicrobial BSI, and unknown source of 
GNBSI.
Multivariate analysis for primary outcome
On multivariate analysis, following variables (odds ratio 
OR in the brackets) were associated with poor outcome: 
every single year increase in age (OR 1.05), every mmHg 
lower mean arterial pressure (OR 1.03), every unit drop 
in mmol of serum bicarbonate (OR 1.08), every single 
unit rise in EWS at the time of GNBSI (OR 1.27), every 
single unit rise in SOFA score (OR 1.36), hospital-onset 
of GNBSI (5.43) and need for vasopressor agents (OR 
16.4) (Table 3).
Systemic inflammatory response syndrome (SIRS) criteria 
at the time of GNBSI
In our cohort, the following proportion of patients trig-
gered individual SIRS criteria- 63  % temperature (<36 
or >38 °C); 72 % tachycardia (HR >90 bpm); 60 % abnor-
mal white blood cell count (<4 or  >12); and 28  % Res-
piratory rate  >20 or PaCO2  <4.26. We did not record 
respiratory rate in all of our patients. However 45  % of 
Table 1 Infection source and primary outcome




  Count 25 7 32
  % Within infection source 78.1 21.9 100.0
 Hepatobiliary
  Count 34 4 38
  % Within infection source 89.5 10.5 100.0
 Lower resp. tract
  Count 12 6 18
  % Within infection source 66.7 33.3 100.0
 Skin and soft tissue
  Count 12 7 19
  % Within infection source 63.2 36.8 100.0
 Uncertain
  Count 28 15 43
  % Within infection source 65.1 34.9 100.0
 Urinary tract
  Count 79 16 95
  % Within infection source 83.2 16.8 100.0
Total
 Count 190 55 245
 % Within infection source 77.6 22.4 100.0
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patients had blood gas measurements giving PaCO2 value 
and in remaining 55 % of patients, we derived the respira-
tory rate by analysing all six components of EWS. Only 9 
(3.7 %) patients had a zero SIRS score. Based on the num-
ber of SIRS criteria 0–4, there is some suggestion as to 
proportionate increase in mortality with each point rise 
in SIRS score, but this was not statistically significant 
(p = 0.25) (Fig. 1).
Early warning score and primary outcome
EWS at the time of GNBSI, and the highest EWS on day 
one and day two were significantly higher in patients who 
died by 28 days. The mean daily highest EWS for the first 
14  days from the onset of GNBSI was also significantly 
higher in patients who died by 28 days (Table 4). Failure 
of EWS to decrease by two points at 48 h was also associ-
ated with poor outcome.
Early warning score and survival analysis
Kaplan–Meier survival curves indicate a clear impact of 
EWS on primary outcome both at the time of onset of 
GNBSI and average EWS for the first 14 days after onset 
of GNBSI (Fig.  2a, b). Higher EWS was associated with 
poor survival. A failure to improve EWS by two points 
at 24 and 48  h was also associated with poor outcome 
(Fig. 3a, b).
Table 2 Univariate analysis for primary outcome
Scale variables Alive mean ± STD Dead mean ± STD 95 % CI p value
 Age 69 ± 17 75 ± 15 2 to 12 0.01
 Charlson’s co-morbidity index 4.8 ± 2.9 6.7 ± 2.5 0.8 to 2.5 0.0001
 Temperature at the time of BSI 38.3 ± 1 37.5 ± 1.4 −1.2 to −0.4 0.0001
 Mean arterial pressure at onset of GNBSI 83 ± 17 73 ± 16 −16 to −6 0.0001
 Oxygen saturation at onset of GNBSI 95.5 ± 3.4 93.9 ± 5.9 −2.8 to −0.3 0.015
 Glasgow coma scale 14.7 ± 0.7 13.7 ± 1.8 −1.5 to −0.5 0.0001
 Sequential Organ Failure (SOFA) 2.9 ± 2.3 5.8 ± 3.5 1.9 to 3.9 0.0001
 EWS at the onset of GNBSI 3.4 ± 2.2 5.6 ± 2.6 1.4 to 2.8 0.0001
 C-reactive protein 134 ± 104 190 ± 127 18 to 93 0.004
 Serum bicarbonate 23 ± 5 20 ± 5 −3.6 to −0.6 0.007
 Time interval-admission to GNBSI (days) 6.4 ± 14 10 ± 14 −0.7 to 7.8 0.1
 Time interval-collection to positivity (h) 1.6 ± 0.8 1.2 ± 0.6 −0.5 to −0.1 0.001
 Time to first antibiotic (h) 18.7 ± 22.8 10.7 ± 17 −13.8 to −2.3 0.006
 Time to appropriate antibiotic (h) 19.6 ± 24 14.6 ± 18 −12.8 to 2.4 0.186
 Time to source control (days) 1.9 ± 2.1 0.64 ± 0.8 −3.2 to 0.6 0.18
Categorical variable Percentage Percentage p value
 Gender: female/male 79/76 21/24 0.5
 BSI onset: hospital/community 64/85 36/15 0.0001
 BSI onset: out of h/routine h 81/73 19/27 0.147
 Patient on oxygen/not on oxygen 57/89 43/11 0.009
 On vasopressor/not on vasopressor 46/79 54/21 0.009
 Polymicrobial BSI/monomicrobial BSI 55/80 45/20 0.007
 ESBL positive/ESBL negative 73/78 27/22 0.7
 Source of BSI: unknown/hepato-biliary 65/90 35/10 0.033
Table 3 Multivariate analysis for primary outcome
a For each year increase in age
b For each mmHg fall in MAP
c For each mmol drop in HCO3
d For each unit increase in EWS score
e For each unit increase in SOFA score
Variable Risk 95 % CI p value
Agea 1.05 1.01–1.08 0.005
Mean arterial pressureb 1.03 1.0–1.05 0.014
Serum bicarbonatec 1.08 1.0–1.16 0.039
Early warning scored 1.27 1.04–1.56 0.02
Sequential Organ Failure Scoree 1.36 1.12–1.65 0.002
BSI onset-hospital 5.43 2.23–12.85 0.0001
Vasopressor on day of BSI (yes) 16.4 2.07–125 0.008
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Receiver operating characteristic (ROC) analysis 
of predictive value of EWS
ROC analysis was undertaken to estimate the predictive 
value of EWS for mortality, both at the time of bacterae-
mia as well as over defined time periods prior to and after 
bacteraemia. ROC curves were calculated for the EWS 
score on the day of bacteraemia, the day prior and the 
day after, and for the average EWS score calculated for 
five discrete time periods: the 7  days prior to bacterae-
mia, the 3 days before and after bacteraemia, the 7 days 
after bacteraemia, the 14  days after bacteraemia, and 
the whole time period (7 days before, and 14 days after). 
The area under the curve (AUC) for 28-days mortality is 
shown in Table 5.
Discussion
Our study reiterates the multifactorial interaction and 
influence on clinical outcome of patients with sepsis 
caused by GNBSI. On multivariate analysis several fac-
tors (modifiable and non-modifiable) influenced clinical 
outcome including old age, low mean arterial pressure, 
acidosis, requirement for vasopressors, higher EWS, 
presence of multi-organ failure (high SOFA score), higher 
comorbidity score, time to appropriate antimicrobial 
therapy and health-care onset. Although these findings 
have been well described and reported in the literature, 
this study shows the value in terms of predicting clinical 
outcome by a simple bedside tool. A higher EWS at the 
onset and mean EWS over first 2 weeks after GNBSI with 
sepsis had a poor outcome. A failure to improve EWS 
by two points from baseline (i.e. at the onset of GNBSI) 
within 24 and 48 h was associated with a poor outcome. 
In terms of predictive value, a single EWS data at any 
time point on its own has a limited value, but a EWS 
trend over a period of time is excellent in predicting the 
mortality. For example, EWS score on day 0 is moderately 
predictive of mortality (AUC 0.72), and adding subse-
quent EWS data improves the models ability to predict 
mortality (Fig. 4). An EWS of ≥6 on day 0 was associated 
with a 70 % mortality, yet an average EWS of two or more 
throughout 14 days was associated with a 61 % mortality 
(Fig. 5). Also EWS showed a very limited predictive value 
prior to the onset of bacteraemia, but it has a very good 
predictive value after this event. This emphasises the fact 
that the derangements in acute physiological parameters 
as reflected in higher EWS is due to sepsis caused by 
GNBSI rather than comorbid conditions.
We chose to use the EWS at the time of collection of 
blood cultures and subsequently the daily highest value 
instead of an average EWS per day. This is because of the 
variability in the number of times the observations will 
be recorded between patients and the inevitable fluctua-
tion of EWS over the course of 24  h in a given patient. 
Both of them can significantly skew the EWS value. 
Instead we wanted to focus on the most severe deranged 
acute physiological status per day secondary to infection, 
and a trend over a period of time (in days) in response 
to therapy. In our healthcare setting, EWS score is regu-
larly measured for all admitted patients as per National 
Institute of Clinical Excellence (NICE) guidelines, at least 
four hourly. Any patient with an EWS score >4 due to any 
medical condition (not just sepsis) will trigger an emer-
gency medical team (EMT) review patient within 30 min. 
Therefore patients with an EWS score (>4) at the time of 
collection of blood cultures in our cohort, received their 
antibiotic significantly earlier than patients with EWS <4 
(mean difference of about 5–6 h earlier) p = 0.047 95 % 
CI (0.07–11.6). This is reflected in the time to initiation 
of appropriate antibiotic therapy amongst patients who 
died is paradoxically shorter than the survivors. Similarly 
patients with a higher EWS score (>4) had their source 
control procedure earlier than patients with EWS  <4 
(mean difference of about half-day), but this was not sta-
tistically significant p = 0.368; 95 % CI (−1.13 to 2.54).
A number of studies have been done in recent years 
assessing the relationship between EWS in sepsis (or 
infections) and mortality or ICU transfer [14–19]. All 
of these studies (except one) have assessed the prog-
nostic ability of a single EWS value, and overall it was 
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Fig. 1 SIRS* criteria of our cohort and 28-day mortality. S0 no SIRS 
criteria met; S1 1 out of 4 SIRS criteria met; S2 2 out of 4 SIRS criteria 
met; S3 3 out of 4 SIRS criteria met and S4 4 out of 4 SIRS criteria met
Table 4 Early warning score changes and  impact on  out-
come
Variable Alive Dead 95 % CI p value
EWS day 0 3.4 ± 2.2 5.6 ± 2.6 1.4–2.8 <.0001
Average EWS day 0–14 1.3 ± 1.4 4.8 ± 2.7 2.8–4.3 <.0001
EWS day 1 2.0 ± 1.9 3.4 ± 2.2 0.8–2.0 <.0001
EWS day 2 1.4 ± 1.6 2.6 ± 2.1 0.7–1.9 <.0001
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Fig. 2 a Kaplan–Meier survival curve for EWS score day 0. b Kaplan–Meier survival curve for average EWS score over 14 days
Page 7 of 10Albur et al. Ann Clin Microbiol Antimicrob  (2016) 15:23 
Fig. 3 a Kaplan–Meier survival curve for EWS score drop within 24 h after the onset of GNBSI. b Kaplan–Meier survival curve for EWS score drop 
within 48 h after the onset of GNBSI
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modest (AUC around 0.63) similar to our study (AUC 
0.71) in terms of discrimination between those likely 
to die or survive. A single case control study from New 
York examining the ICU transfer of ward-based patients, 
showed slightly better discrimination value (AUC 0.73) 
using an average EWS over 72  h [20]. However, com-
parison between studies is difficult, as noted in a recent 
systematic review as most departments adapt or modify 
their EWS scoring criteria [21].
Serum lactate has been hailed as a surrogate marker 
of organ perfusion (hence severity of sepsis) and forms 
an important key element in the sepsis bundle [22]. 
However it is an invasive test with associated costs and 
subjected to availability especially in resource poor set-
tings. Serum lactate is also elevated in wide variety of 
conditions other than sepsis [23]. A number of immune/
inflammatory markers have been studied in the diagno-
sis, management of sepsis including assessing the sever-
ity and predicting clinical outcomes [24]. Although some 
of them (CRP, procalcitonin) are routinely used in clini-
cal practice to assess the responsiveness of antimicrobial 
therapy, their role in assessing the severity of infection 
and predicting clinical outcomes is limited [25].
There are a number of sophisticated disease severity 
scoring systems in use especially in the critical care set-
ting including SOFA, SAP, and APACHE II etc. In our 
study, SOFA score measured at the time of collection of 
blood cultures showed good correlation with clinical out-
come. On multivariate analysis, every single point rise in 
SOFA score increased the mortality by 36  %. However 
timely measurement of these complex scoring systems at 
the bedside is virtually impossible even with an advanced 
electronic data management systems. EWS can be meas-
ured in an out of hospital settings in remote areas, and 
Table 5 ROC analysis of predictive value of EWS
Time period AUC (95 % CI) for  
28 days mortality
EWS on day prior to bacteraemia 0.53 (0.42–0.64)
EWS on day of bacteraemia 0.72 (0.64–0.81)
EWS on day 1 after bacteraemia 0.73 (0.64–0.81)
Average EWS 7 days prior to bacteraemia 0.62 (0.53–0.70)
Average EWS 3 days before and 3 days after  
bacteraemia
0.79 (0.72–0.86)
Average EWS 3 days after bacteraemia 0.82 (0.75–0.89)
Average EWS 7 days after bacteraemia 0.90 (0.85–0.95)
Average EWS 14 days after bacteraemia 0.92 (0.88–0.97)
Average EWS 7 days prior, and 14 days after  
bacteraemia
0.89 (0.84–0.94)
Fig. 4 Area under the curve (AUC) for mortality prediction by EWS trend
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hence can be useful in resource poor countries. The 
major burden of sepsis and higher mortality second-
ary to sepsis are most prevalent in poor countries where 
sophisticated laboratory tests and invasive hemodynamic 
monitoring are unavailable [1]. Hence implementation of 
surviving sepsis guidelines in resource poor settings can 
be challenging if not impossible.
EWS is a simple, non-invasive and easy-to-repeat 
measurement that can be recorded by any trained 
healthcare worker within 1  min. EWS can be measured 
on multiple occasions in quick succession to follow the 
trend and assess the impact of interventions. Therefore 
EWS is an ideal marker of severity of sepsis, and dynamic 
changes in EWS will not only help to predict the outcome 
but also trigger timely interventions such as fluid balance, 
oxygenation, ICU transfer, and organ support. A targeted 
correction of EWS by means of judicious use of intrave-
nous fluids, oxygen, and organ support such as vasopres-
sors/inotropes may improve clinical outcome rather than 
focussing on blood pressure alone or relying on invasive 
hemodynamic monitoring such as mixed-venous satura-
tion. We estimated the cost of measuring each EWS score 
as 46 pence based on time spent by the healthcare worker 
and the cost of the automated observation recording 
equipment. These costs will be even lower in a develop-
ing world because of the subsidies for the equipment and 
the lower salary scale. However the cost of performing a 
full laboratory tests including serum lactate would be sig-
nificantly higher.
Our study has a few limitations, mainly in the form of 
number of patients enrolled and a specific type of infec-
tion (GNBSI) causing sepsis. However despite relatively 
low number of patients, this is a prospective study with a 
robust data set and having nearly a 100 % follow-up rate 
conducted by a dedicated infection specialist team. We 
deliberately chose GNBSI because significant proportions 
of Gram-positive bacteraemia are skin contaminants and 
only 3 out of 252 cases were deemed contaminants in our 
study. E. coli is the most common cause of bacteraemia 
in the UK, and Gram-negative bacteraemia has surpassed 
Gram-positive bacteraemia in the last decade or so. Also 
the antimicrobial resistance amongst Gram-negative bac-
teria is increasing and this has led to additional challenges 
in terms of choosing empirical therapy in patients with 
GNBSI until the susceptibility results are known. In our 
cohort, the time to first antibiotic is significantly shorter 
in patients who died as compared to who survived, which 
is in contrast to a popular retrospective study [26]. This is 
because, patients who died had a higher EWS score and 
hence were likely to have been prioritised in their care as 
compared to those who survived.
Conclusion
EWS is a simple, cost-effective, and non-invasive bed-
side tool which is easy to record and can be repeated 
any number of times by a trained healthcare worker. A 
higher EWS at the onset and subsequent trend of slug-
gish decrease over 2  weeks after the onset of GNBSI is 
associated with poor outcome. Failure to decrease by 2 
points within the first 24–48  h is also associated with 
poor outcome. Timely correction of EWS by judicious 
use of fluids and oxygenation in addition to appropriate 
antimicrobial therapy plus removal of focus of infection 
may improve clinical outcome. Large multicentre pro-
spective randomised control studies against sepsis of any 
infective pathogen(s) or source is needed to explore these 
findings especially in resource poor settings.
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